Pharmacotherapy prior to and in acute haemorrhagic stroke. The use of pharmacotherapy and drugs-associated outcomes in real-world practice - Findings from the Polish Hospital Stroke Registry;Farmakoterapia w okresie poprzedzaja{ogonek}cym wysta{ogonek}pienie udaru i w ostrym udarze krwotocznym. Zastosowanie oraz wpływ leków na wyniki leczenia udaru krwotocznego mózgu w codziennej praktyce klinicznej - Wyniki Szpitalnego Rejestru Udarów Mózgu w Polsce

Neurologia i Neurochirurgia Polska

Volumn 47, Issue 6, 2013, Pages 517-524

  Niewada, Maciej ^a   Skowrońska, Marta ^b   Sarzyńska Długosz, Iwona Marta ^b   Kamiński, Bogumił ^c   Kobayashi, Adam ^a   Członkowska, Anna ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b II Klinika Neurologiczna   (Poland)

^c WARSAW SCHOOL OF ECONOMICS   (Poland)

Author keywords

Antihyper tensives; Haemorrhagic stroke; Oral anticoagulants; Pharmacotherapy; Statins

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEUROPROTECTIVE AGENT; TRIACYLGLYCEROL; VASOACTIVE AGENT;

AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; INFECTION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; QUESTIONNAIRE; RANKIN SCALE; TREATMENT OUTCOME;

EID: 84890100870     PISSN: 00283843     EISSN: 18974260     Source Type: Journal    
DOI: 10.5114/ninp.2013.39068     Document Type: Article

References (30)

1. Broderick J., Connolly S., Feldmann E., et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/ American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007; 38: 2001-2023.
2. Fogelholm R., Murros K., Rissanen A., et al. Long term survival after primary intracerebral haemorrhage: a retrospective population based study. J Neurol Neurosurg Psychiatry 2005; 76: 1534-1538.
3. Kase C.S., Kurth T. Prevention of intracerebral hemorrhage recurrence. Continuum 2011; 17: 1304-1317.
4. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack. A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2011; 42: 227-276.
5. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
6. Niewada M., Sarzyñska-Długosz I., Skowroñska M., et al. Pharmacotherapy prior to and in acute ischaemic stroke. The use of pharmacotherapy and drugs associated outcomes in real-world practice - findings from the Polish Hospital Stroke Registry. Neurol Neurochir Pol 2013; 47: 509-516.
7. O'Donnell M.J., Xavier D., Liu L., et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010; 376: 112-123.
8. Flaherty M.L., Kissela B., Woo D., et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology 2007; 68: 116-121.
9. Flaherty M.L., Haverbusch M., Sekar P., et al. Long-term mortality after intracerebral hemorrhage. Neurology 2006; 66: 1182-1186.
10. Rosand J., Eckman M.H., Knudsen K.A., et al. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Int Med 2004; 164: 880-884.
11. Westendorp W.F., Nederkoorn P.J., Vermeij J.D., et al. Post-stroke infection: a systematic review and meta-analysis. BMC Neurology 2011; 11: 110.
12. Stead L.G., Jain A., Bellolio M.F., et al. Effect of anticoagulant and antiplatelet therapy in patients with spontaneous intra-cerebral hemorrhage: Does medication use predict worse outcome? Clin Neurol Neurosurg 2010; 112: 275-281.
13. Saloheimo P., Ahonen M., Juvela S., et al. Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death. Stroke 2006; 37: 129-133.
14. Flibotte J.J., Hagan N., O'Donnell J., et al. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 2004; 63: 1059-1064.
15. Wong K.S., Mok V., Lam W.W., et al. Aspirin-associated intracerebral hemorrhage: clinical and radiologic features. Neurology 2000; 54: 2298-2301.
16. Wong K.S. Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage. Neurology 2006; 66: 1610-1611.
17. Toyoda K., Okada Y., Minematsu K., et al. Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage. Neurology 2005; 65: 1000-1004.
18. Roquer J., Rodríguez Campello A., Gomis M., et al. Previous antiplatelet therapy is an independent predictor of 30-day mortality after spontaneous supratentorial intracerebral hemorrhage. J Neurol 2005; 252: 412-416.
19. Hanger H.C., Fletcher V.J., Wilkinson T.J., et al. Effect of aspirin and warfarin on early survival after intracerebral haemorrhage. J Neurol 2008; 255: 347-352.
20. Sansing L.H., Messe S.R., Cucchiara B.L., et al. Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH. Neurology 2009; 72: 1397-1402.
21. Thompson B.B., Bejot Y., Caso V., et al. Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology 2010; 75: 1333-1342.
22. FitzMaurice E., Wendell L., Snider R., et al. Effect of statins on intracerebral hemorrhage outcome and recurrence. Stroke 2008; 39: 2151-2154.
23. Eichel R., Khoury S.T., Ben-Hur T., et al. Prior use of statins and outcome in patients with intracerebral haemorrhage. Eur J Neurol 2010; 17: 78-83.
24. Romero F.R., Bertolini Ede F., Veloso V.N., et al. Outcomes from intracerebral hemorrhage among patients pre-treated with statins. Arq Neuropsiquiatr 2011; 69: 452-454.
25. Biffi A., Devan W.J., Anderson C.D., et al. Statin use and outcome after intracerebral hemorrhage: case-control study and meta-analysis. Neurology 2011; 76: 1581-1588.
26. Gomis M., Ois A., Rodriguez-Campello A., et al. Outcome of intracerebral haemorrhage patients pre-treated with statins. Eur J Neurol 2010; 17: 443-448.
27. Leker R.R., Khoury S.T., Rafaeli G., et al. Prior use of statins improves outcome in patients with intracerebral hemorrhage: prospective data from the National Acute Stroke Israeli Surveys (NASIS). Stroke 2009; 40: 2581-2584.
28. Naval N.S., Abdelhak T.A., Zeballos P., et al. Prior statin use reduces mortality in intracerebral hemorrhage. Neurocrit Care 2008; 8: 6-12.
29. Amarenco P., Bogousslavsky J., Callahan A. 3rd, et al. High-dose atorvastatin after stroke or transient ischaemic attack. N Engl J Med 2006; 355: 549-559.
30. Goldstein L.B., Amarenco P., Szarek M., et al. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology 2008; 70: 2364-2370.